NCT02057380 2024-11-20A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib TrialAstellas Pharma IncPhase 2 Completed13 enrolled
NCT05214976 2022-12-22A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of PatientsJiangsu HengRui Medicine Co., Ltd.Phase 2 Unknown64 enrolled